DVxTSE:3079 -0.10%63 EBITDA Margin % is 2.24% as of Mar. 2026, which is 33% below its 10-year median of 3.33. GuruFocus rates TSE:3079 with a GF Score™ of 63/100 and a GF Value™ of 円1,183.84 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 816 Medical Devices & Instruments companies, DVx ranks worse than 58.82% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. DVx's EBITDA for the
six
months ended in Mar. 2026 was 円634 Mil. DVx's Revenue for the
six
months ended in Mar. 2026 was 円28,354 Mil. Therefore, DVx's EBITDA margin for the quarter that ended in Mar. 2026 was 2.24%.
DVx (TSE:3079) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
DVx EBITDA Margin % Related Terms
DVx EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for DVx's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3079 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, DVx's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DVx EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, DVx's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where DVx's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DVx (TSE:3079) has a EBITDA Margin % of 2.24% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on DVx and its competitors. This is 33% below median its historical median of 3.33. Over the past decade, DVx's EBITDA Margin % has ranged from 1.76 to 4.63. According to the industry distribution chart, DVx ranks #480 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 58.8%.
Is DVx's EBITDA Margin % too high?
DVx's current EBITDA Margin % of 2.24% is 33% below median its 10-year median of 3.33. Over the past 10 years, this metric has ranged from a low of 1.76 to a high of 4.63. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. DVx's value of 2.24% is 70% below this industry median. Based on the distribution chart, DVx ranks #480 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, DVx has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DVx's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, DVx ranks #480 out of 816 companies for EBITDA Margin %. This places DVx in the lower half of its industry. The industry median EBITDA Margin % is 7.48. DVx's value of 2.24% is 70% below this benchmark. Historically, DVx's own EBITDA Margin % has ranged from 1.76 to 4.63 over the past decade. While the company's 10-year median is 3.33 vs. the industry median of 7.48, DVx has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DVx's current EBITDA Margin % of 2.24% is 70% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on DVx and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DVx's current EBITDA Margin % is 2.24%, which is 33% below median its own 10-year median of 3.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DVx stock overvalued right now?
Based on GuruFocus' analysis, DVx (TSE:3079) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,183.84, compared to a current price of 円993.00 — trading 16.1% below its estimated fair value. The current EBITDA Margin % is 2.24%, which is 33% below median its 10-year median of 3.33 and 70% below the Medical Devices & Instruments industry median of 7.48. DVx's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For DVx (TSE:3079), the current EBITDA Margin % is 2.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DVx (TSE:3079) Overvalued in 2026?
Based on GuruFocus' analysis, DVx stock appears to be undervalued.
The current stock price of 円993.00 is trading 16.1% below its estimated GF Value™ of 円1,183.84.
GuruFocus considers DVx to be Modestly Undervalued.
Key valuation signals for TSE:3079:
EBITDA Margin %: 2.24% (33% below median its 10-year median of 3.33)
GF Value™: 円1,183.84 vs. price of 円993.00 (16.1% below fair value)
Industry Position: 70% below the Medical Devices & Instruments median (#480 of 816)
No single metric tells the full story. See the TSE:3079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DVx Inc is engaged in manufacture, sale, repair, and leasing of medical equipment and related peripheral equipment, research and development of medical equipment, provide in house and out of service consulting services and services for medical and medical devices, and providing medical publication and market research.
63GF Score
Get the complete analysis for TSE:3079
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3079 has been successfully added to your 
